Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency

Journal of Inherited Metabolic Disease

Volumn 30, Issue 5, 2007, Pages 673-680

  Sauer, Sven W ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYGLUTAMIC ACID; DICARBOXYLIC ACID; GLUTARIC ACID; GLUTARYL COENZYME A DEHYDROGENASE; HYDROXYLYSINE; LYSINE; OXOGLUTARATE DEHYDROGENASE; TRYPTOPHAN;

ACIDURIA; ARTICLE; AUTOPSY; AUTOSOMAL RECESSIVE DISORDER; BIOACCUMULATION; BIOENERGY; BLOOD BRAIN BARRIER; BODY FLUID; BRAIN DEGENERATION; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN TISSUE; CATABOLISM; CATALYSIS; CORPUS STRIATUM; DECARBOXYLATION; DEGENERATIVE DISEASE; ENZYME DEFICIENCY; ENZYME INHIBITION; EXCITOTOXICITY; HUMAN; IN VITRO STUDY; MOUSE STRAIN; NONHUMAN; PATHOPHYSIOLOGY; TISSUE SPECIFICITY;

ACYL COENZYME A; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN DISEASES, METABOLIC, INBORN; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; GLUTARATES; GLUTARYL-COA DEHYDROGENASE; HUMANS; KETOGLUTARATE DEHYDROGENASE COMPLEX; MICE; MICE, KNOCKOUT; NEURONS;

EID: 35248895736     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-007-0678-8     Document Type: Article

References (76)

1. Baric I, Wagner L, Feyh P, Liesert M, Buckel W, Hoffmann GF (1999) Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I. J Inherit Metab Dis 22: 867-881.
2. Beal MF, Swartz KJ, Hyman BT, Storey E, Finn SF, Koroshetz W (1991) Aminooxyacetic acid results in cxcitotoxin lesions by a novel indirect mechanism. J Neurochem 57: 1068-1073.
3. Bennett JP, Logan WJ, Snyder SH (1973) Amino acids as central nervous transmitters: The influence of ions, amino acid analogues, ontogeny on transport systems for l -glutamic and l -aspartic acids and glycine into central nervous synaptosomes of the rat. J Neurochem 21: 1533-1550.
4. Bennett MJ, Marlow N, Pollitt RJ, Wales JK (1986) Glutaric aciduria type 1: Biochemical investigations and postmortem findings. Eur J Pediatr 145: 403-405.
5. Bernardi P, Krauskopf A, Basso E, et al (2006) The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J 273: 2077-2099.
6. Brismar J, Ozand PT (1995) CT and MR of the brain in glutaric acidemia type I: A review of 59 published cases and a report of 5 new patients. Am J Neuroradiol 16: 675-683.
7. Buerstatte CR, Behar KL, Novotny EJ, Lai JC (2000) Brain regional development of the activity of alpha-ketoglutarate dehydrogenase complex in the rat. Brain Res Dev Brain Res 125: 139-145.
8. Busquets C, Merinero B, Christensen E, et al (2000) Glutaryl-CoA dehydrogenase deficiency in Spain: Evidence of two groups of patients, genetically, and biochemically distinct. Pediatr Res 48: 315-322.
9. Christensen E, Ribes A, Merinero B, Zschocke J (2004) Correlation of genotype and phenotype in glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 861-868. dehydrogenase locus.
10. De Mello CF, Kölker S, Ahlemeyer B, et al (2001) Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and excitotoxic lesions in rats. Brain Res 916: 70-75.
11. Ferreira G da C, Viegas CM, Schuck PF, et al (2005a) Glutaric acid moderately compromises energy metabolism in rat brain. Int J Dev Neurosci 23: 687-693.
12. Ferreira G da C, Viegas CM, Schuck PF, et al (2005b) Glutaric acid administration impairs energy metabolism in midbrain and skeletal muscle of young rats. Neurochem Res 30: 1123-1131.
13. Ferreira GD, Schuck PF, Viegas CM, et al (2007) Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid. Metab Brain Dis 22 (1): 111-123. Epub 2007 Jan 13.
14. Flott-Rahmel B, Falter C, Schluff P, et al (1997) Nerve cell lesions caused by 3-hydroxyglutaric acid: A possible mechanism for neurodegeneration in glutaric acidaemia type I. J Inherit Metab Dis 20: 387-390.
15. Freudenberg F, Lukacs Z, Ullrich K (2004) 3-Hydroxyglutaric acid fails to affect the viability of primary neuronal rat cells. Neurobiol Dis 16: 581-584.
16. Fu Z, Wang M, Paschke R, Rao KS, Frerman FE, Kim JJ (2004) Crystal structures of human glutaryl-CoA dehydrogenase with and without an alternate substrate: Structural bases of dehydrogenation and decarboxylation reactions. Biochemistry 43: 9674-9684.
17. Funk CB, Prasad AN, Del Bigio MR (2004) Attempts to establish a rat model of striatal injury in glutaric acidaemia type I. J Inherit Metab Dis 27: 819-824.
18. Funk CB, Prasad AN, Frosk P, et al (2005) Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. Brain 128: 711-722.
19. Gerstner B, Gratopp A, Marcinkowski M, Sifringer M, Obladen M, Buhrer C (2005) Glutaric acid and its metabolites cause apoptosis in immature oligodendrocytes: A novel mechanism of white matter degeneration in glutaryl-CoA dehydrogenase deficiency. Pediatr Res 57: 771-776.
20. Gibson GE, Sheu RKF, Blass JP, et al (1988) Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol 45: 836-840.
21. Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977) Glutaric aciduria: Biochemical and morphological considerations. J Pediatr 90: 746-750.
22. Goodman SI, Stein DE, Schlesinger S, et al (1998) Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): Review and report of thirty novel mutations. Hum Mutat 12: 141-144.
23. Greenberg CR, Reimer D, Singal R, et al (1995) A G-to-T transversion at the +5 position of intron 1 in the glutaryl CoA dehydrogenase gene is associated with the Island Lake variant of glutaric acidemia type I. Hum Mol Genet 4: 493-495.
24. Greenberg CR, Prasad AN, Dilling LA, et al (2002) Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada. Mol Genet Metab 75: 70-78
25. Hassel B, Brathe A, Petersen DJ (2002) Cerebral dicarboxylate transport and metabolism studied with isotopically labelled fumarate, malate and malonate. J Neurochem 82: 410-419.
26. Hassel B, Brathe A (2000) Cerebral metabolism of lactate in vivo: evidence for neuronal pyruvate carboxylation. J Neurosci 20: 1342-1347.
27. Heyes MP (1987) Hypothesis: A role for quinolinic acid in the neuropathology of glutaric aciduria type I. Can J Neurol Sci 14: 441-443.
28. Hoffmann GF, Athanassopoulos S, Burlina AB, et al (1996) Clinical course, early diagnosis, treatment, prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics 27: 115-123.
29. Huang HM, Ou HC, Xu H, Chen HL, Fowler C, Gibson GE (2003) Inhibition of alpha-ketoglutarate dehydrogenase complex promotes cytochrome c release from mitochondria, caspase-3 activation, necrotic cell death. J Neurosci Res 74: 309-317.
30. Klivenyi P, Starkov AA, Calingasan NY, et al (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. J Neurochem 88: 1352-1360.
31. Koeller DM, Woontner M, Crnic LS, et al (2002) Biochemical, pathological and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mol Genet 11: 347-357.
32. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2000) Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: A new pathophysiological approach to glutaryl-CoA dehydrogenase deficiency. Pediatr Res 47: 495-503.
33. Kölker S, Ahlemeyer B, Krieglstein J, Hoffmann GF (2001a) Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 50: 76-82.
34. Kölker S, Ahlemeyer B, Hühne R, Mayatepek E, Krieglstein J, Hoffmann GF (2001b) Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures. Eur J Neurosci 13: 2115-2122.
35. + dependence of 3-hydroxyglutarate-induced excitotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr Res 52: 199-206.
36. Kölker S, Okun JG, Ahlemeyer B, et al (2002b) Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J Neurosci Res 68: 424-431.
37. Kölker S, Hoffmann GF, Schor DS, et al (2003) Glutaryl-CoA dehydrogenase deficiency: Region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 34: 253-260.
38. Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004) Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55: 7-12.
39. Kölker S, Garbade SF, Greenberg CR et al (2006a) Natural history, outcome, and treatment efficacy in children and adults with glutaryl-CoA degydrogenase deficiency. Pediatr Res 59: 840-847.
40. Kölker S, Sauer SW, Surtees RA, Leonard JV (2006b) The aetiology of neurological complications of organic acidaemias - A role for the blood-brain barrier. J Inherit Metab Dis 29: 701-704.
41. Kölker S, Christensen E, Leonard JV, et al (2007) Guideline for the diagnosis and managment of glutaryl-CoA dehydrogenase deficiency (glutaric aciduria type I) J Inherit Metab Dis 30: 5-22.
42. Külkens S, Harting I, Sauer S, et al (2005) Late-onset neurological disease in glutaryl-CoA dehydrogenase deficiency. Neurology 64: 2142-2144.
43. Kyllerman M, Skjeldal O, Christensen E, et al (2004) Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol 8: 121-129.
44. Latini A, Borba Rosa R, Scussiato K, Llesuy S, Bello-Klein A, Wajner M (2002) 3-Hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats. Brain Res 956: 367-373.
45. Latini A, Rodriguez M, Borba Rosa R, et al (2005) 3-Hydroxyglutaric acid moderately impairs energy metabolism in brain of young rats. Neuroscience 135: 111-120.
46. Leibel RL, Shih VE, Goodman SI, et al (1980) Glutaric acidemia: A metabolic disorder causing progressive choreoathetosis. Neurology 30: 1163-1168.
47. Lindner M, Kölker S, Schulze A, Christensen E, Greenberg CR, Hoffmann GF (2004) Neonatal screening for glutaryl-CoA dehydrogenase deficiency. J Inherit Metab Dis 27: 851-859.
48. Lund TM, Christensen E, Kristensen E, Schousboe A, Lund AM (2004) On the neurotoxicity of glutaric, 3-hydroxyglutaric, and trans-glutaconic acids in glutaric aciduria type 1. J Neurosci Res 77: 143-147.
49. Mizuno Y, Matsuda S, Yoshino H, Mori H, Hattori N, Ikebe SI (1994) An immunohistochemical study on alpha-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol 35: 204-210.
50. Mizuno Y, Ikebe S, Hattori N, et al (1995) Role of mitochondria in the etiology and pathogenesis of Parkinson's disease. Biochim Biophys Acta 1271: 265-274.
51. Muhlhausen C, Ott N, Chalajour F, et al (2006) Endothelial effects of 3-hydroxyglutaric acid: Implications for glutaric aciduria type I. Pediatr Res 59: 196-202.
52. Naughten ER, Mayne PD, Monavari AA, Goodman SI, Sulaiman G, Croke DT (2004) Glutaric aciduria type I: Outcome in the Republic of Ireland. J Inherit Metab Dis 27: 917-920.
53. Neumaier-Probst E, Harting I, Seitz A, Ding C, Kolker S (2004) Neuroradiological findings in glutaric aciduria type I (glutaryl-CoA dehydrogenase deficiency) J Inherit Metab Dis 27: 869-876.
54. Novelli A, Reilly JA, Lysko PG, Henneberry RC (1988) Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced. Brain Res 451: 205-212.
55. Olney JW, Sharpe LG (1969) Brain lesions in an infant rhesus monkey treated with monsodium glutamate. Science 166: 386-388.
56. 3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro. J Neurol Sci 73: 93-96.
57. Rosa RB, Schwarzbold C, Dalcin KB, et al (2004) Evidence that 3-hydroxyglutaric acid interacts with NMDA receptors in synaptic plasma membranes from cerebral cortex of young rats. Neurochem Int 45: 1087-1094.
58. Sauer SW, Okun JG, Schwab MA, et al (2005) Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: A role for glutaryl-coenzyme A. J Biol Chem 280: 21830-21836.
59. Sauer SW, Okun JG, Fricker G, et al (2006) Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiency. J Neurochem 97: 899-910.
60. Schousboe A, Westergaard N, Waagepetersen HS, Larsson OM, Barken IJ, Sonnewald U (1997) Trafficking between glia and neurons of TCA cycle intermediates and related metabolites. Glia 21: 99-105.
61. Silva CG, Silva AR, Ruschel C, et al (2000) Inhibition of energy production in vitro by glutaric acid in cerebral cortex of young rats. Metab Brain Dis 15: 123-131.
62. Stokke O, Goodman SI, Moe PG (1976) Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria? Clin Chim Acta 66: 411-415.
63. Storey E, Hyman BT, Jenkins BT, et al (1992) MPP produces excitotoxic lesions in rat striatum due to impairment of oxidative metabolism. J Neurochem 58: 1975-1978.
64. Strauss KA, Morton DH (2003) Type I glutaric aciduria, part 2: A model of acute striatal necrosis. Am J Med Genet C Semin Med Genet 121: 53-70.
65. Strauss KA, Puffenberger EG, Robinson DL, Morton DH (2003) Type I glutaric aciduria, part 1: Natural history of 77 patients. Am J Med Genet C Semin Med Genet 121: 38-52.
66. Tamai I, Tsuji A (2000) Transporter-mediated permeation of drugs across the blood-brain barrier. J Pharm Sci 89: 1371-1388.
67. Twomey EL, Naughten ER, Donoghue VB, Ryan S (2003) Neuroimaging findings in glutaric aciduria type 1. Pediatr Radiol 33: 823-830.
68. Ullrich K, Flott-Rahmel B, Schluff P, et al (1999) Glutaric aciduria type I: Pathomechanisms of neurodegeneration. J Inherit Metab Dis 22: 392-403.
69. Varadkar S, Surtees R (2004) Glutaric aciduria type I and kynurenine pathway metabolites: A modified hypothesis. J Inherit Metab Dis 27: 835-842.
70. +-dependent high-affinity dicarboxylate transporter. Am J Physiol Cell Physiol 278: C1019-C1030.
71. Woontner M, Crnic LS, Koeller DM (2000) Analysis of the expression of murine glutaryl-CoA dehydrogenase: In vitro and in vivo studies. Mol Genet Metab 69: 116-122.
72. Yodoya E, Wada M, Shimada A, et al (2006) Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem 97: 162-173.
73. Zeevalk GD, Nicklas WJ (1990) Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina. J Pharm Exp Ther 253: 1285-1292.
74. Zeevalk GD, Nicklas WJ (1991) Mechanisms underlying initiation of excitotoxicity associated with metabolic inhibition. J Pharm Exp Ther 257: 870-878.
75. Zinnanti WJ, Lazovic J, Wolpert EB, et al (2006) A diet-induced mouse model for glutaric aciduria type I. Brain 129: 899-910.
76. Zschocke J, Quak E, Guldberg P, Hoffmann GF (2000) Mutation analysis in glutaric aciduria type I. J Med Genet 37: 177-181.